Clinical Trial: The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06792955) titled 'The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution' on Jan. 20.

Brief Summary: The study is being conducted to evaluate the bioequivalence between a single-dose pen and a multi-dose pen of HRS9531 injection solution.

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Overweight/Obesity

Intervention: DRUG: HRS9531 injection

Multi-dose pen of HRS9531 injection solution.

DRUG: HRS9531 injection

Single-dose pen of HRS9531 injection solution.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Disclaimer: Curated by ...